We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Shuren: Animosity Toward FDA Is Hurting Premarket Process
Shuren: Animosity Toward FDA Is Hurting Premarket Process
June 10, 2011
As industry has become more vocal in criticizing the regulatory process for devices, it may actually be hurting, rather than helping, its chances of seeing any real change, CDRH Director Jeffrey Shuren says.